Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GlaxoSmithKline agrees to disclose Unicef prices

GlaxoSmithKline agrees to disclose Unicef prices

19th May 2011

GlaxoSmithKline has said it will publish details of how much it charges Unicef for vaccines.

Britain's largest pharmaceutical firm is working with the humanitarian organisation to enable the retrospective disclosure of prices, as well as information about future transactions, the Telegraph reports.

The company is currently one of the largest suppliers to Unicef, providing it with vaccines for illnesses such as meningitis and hepatitis B.

Although the United Nations organisation began publishing cost data agreed with suppliers for a range of products earlier this year, GlaxoSmithKline is one of several firms that did not initially approve the disclosure of its prices.

The company came under pressure from medical charity Medecins sans Frontieres over the policy and has now decided to change its stance.

A spokesperson for GlaxoSmithKline told the newspaper that the move should help stakeholders to make "informed decisions for future vaccine procurement".

Headquartered in New York, Unicef is active in 190 countries and exists to help children whose lives are affected by poverty, violence and disease.ADNFCR-8000103-ID-800549327-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.